China, Sept. 15 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Intelligent quantification of tumor immune microenvironment based on CT image and digital pathology interpretable model for accurately predicting treatment efficacy to neoadjuvant immunochemotherapy in gastric cancer'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132430

Registration Time: 2026/09/14

Type: Observational study

Primary Sponsor: Shanxi Province Cancer Hospital / Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=322756

Published by HT Digital Content Service...